2020 Vol.38, N°3 - Table of contents
May-June 2020
Editorials
CER13595
2020,38,3
Pg. 0373-0382
Free to view
COVID-19: the new challenge for rheumatologists. First update
F. Ferro, E. Elefante, I. Puxeddu, C. Baldini, E. Bartoloni, C. Baratè, S. Galimberti, R. Talarico, M. Mosca, S. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/yvn0nh
F. Ferro, E. Elefante, I. Puxeddu, C. Baldini, E. Bartoloni, C. Baratè, S. Galimberti, R. Talarico, M. Mosca, S. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/yvn0nh
CER13518
2020,38,3
Pg. 0383-0386
Free to view
Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination
M. Cutolo, V. Smith, S. Paolino
DOI: https://doi.org/10.55563/clinexprheumatol/qb05rr
M. Cutolo, V. Smith, S. Paolino
DOI: https://doi.org/10.55563/clinexprheumatol/qb05rr
One year in review
CER13339
2020,38,3
Pg. 0387-0397
Free to view
One year in review 2020: pathogenesis of rheumatoid arthritis
D. Giannini, M. Antonucci, F. Petrelli, S. Bilia, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/3uj1ng
D. Giannini, M. Antonucci, F. Petrelli, S. Bilia, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/3uj1ng
Full Papers
CER11880
2020,38,3
Pg. 0398-0404
Free to view
Choice of the most appropriate biological disease-modifying anti-rheumatic drug for injection spacing: results from a multicentre observational study
H. Matsuno, K. Katayama, K. Funahashi, M. Saitoh, T. Matsubara
H. Matsuno, K. Katayama, K. Funahashi, M. Saitoh, T. Matsubara
CER12032
2020,38,3
Pg. 0405-0410
Free to view
Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry –RoAcTEmra) Regate registry
J. Morel, M. Locci, F. Banal, B. Combe, G. Cormier, M. Dougados, R.-M. Flipo, C. Marcelli, T. Pham, S. Rist, E. Solau Gervais, J. Sibilia, C. Lukas
J. Morel, M. Locci, F. Banal, B. Combe, G. Cormier, M. Dougados, R.-M. Flipo, C. Marcelli, T. Pham, S. Rist, E. Solau Gervais, J. Sibilia, C. Lukas
CER12180
2020,38,3
Pg. 0411-0419
Free to view
Effects of birth months on rheumatic diseases in South Korea: a nationwide case-control study
J. Lee, J.H. Kim, M.K. Chung, M.-S. Park, S.-K. Kwok, H.W. Yim, S.-H. Park, J.H. Ju
J. Lee, J.H. Kim, M.K. Chung, M.-S. Park, S.-K. Kwok, H.W. Yim, S.-H. Park, J.H. Ju
CER12288
2020,38,3
Pg. 0420-0427
Free to view
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction
G. Cioffi, A. Giollo, G. Orsolini, L. Idolazzi, A. Carletto, F. Ognibeni, A. Dalbeni, D. Gatti, M. Rossini, O. Viapiana
G. Cioffi, A. Giollo, G. Orsolini, L. Idolazzi, A. Carletto, F. Ognibeni, A. Dalbeni, D. Gatti, M. Rossini, O. Viapiana
CER12305
2020,38,3
Pg. 0428-0435
Free to view
Quality improvement for rheumatoid arthritis care: results from a focus group
M. Forman, C. Leatherwood, M.D. Iversen, D.H. Solomon, S.P. Desai
M. Forman, C. Leatherwood, M.D. Iversen, D.H. Solomon, S.P. Desai
CER12076
2020,38,3
Pg. 0436-0441
Free to view
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica.
D. Birra, S.L. Bosello, G. Peluso, A. Zoli
D. Birra, S.L. Bosello, G. Peluso, A. Zoli
CER11986
2020,38,3
Pg. 0442-0449
Free to view
The presence of P2RX7 single nuclear polymorphism is associated with a gain of function in P2X7 receptor and inflammasome activation in SLE complicated with pericarditis
S. Hu, F. Yu, C. Ye, X. Huang, X. Lei, Y. Dai, H. Xu, Y. Wang, Y. Yu
S. Hu, F. Yu, C. Ye, X. Huang, X. Lei, Y. Dai, H. Xu, Y. Wang, Y. Yu
CER12283
2020,38,3
Pg. 0450-0454
Free to view
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study
F. Ceccarelli, V. Orefice, G. Perrone, C. Pirone, C. Perricone, S. Truglia, F. Miranda, V.A. Pacucci, F.R. Spinelli, P. Galoppi, C. Alessandri, G. Valesini, F. Conti
F. Ceccarelli, V. Orefice, G. Perrone, C. Pirone, C. Perricone, S. Truglia, F. Miranda, V.A. Pacucci, F.R. Spinelli, P. Galoppi, C. Alessandri, G. Valesini, F. Conti
CER12156
2020,38,3
Pg. 0455-0466
Free to view
Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis
E. Alemao, R. Postema, Y. Elbez, C. Mamane, A. Finckh
E. Alemao, R. Postema, Y. Elbez, C. Mamane, A. Finckh
CER12325
2020,38,3
Pg. 0467-0471
Free to view
Spinal mobility in the cervical and lumbar spine correlates with magnetic resonance imaging findings for inflammatory and structural changes in patients with active ankylosing spondylitis
X. Baraliakos, K.-G. Hermann, S. Xu, E.C. Hsia, J. Braun
X. Baraliakos, K.-G. Hermann, S. Xu, E.C. Hsia, J. Braun
CER11982
2020,38,3
Pg. 0472-0478
Free to view
How normal is the enthesis by ultrasound in healthy subjects?
A. Di Matteo, E. Filippucci, E. Cipolletta, V. Martire, D. Jesus, A. Musca, D. Corradini, M. Isidori, F. Salaffi, W. Grassi
A. Di Matteo, E. Filippucci, E. Cipolletta, V. Martire, D. Jesus, A. Musca, D. Corradini, M. Isidori, F. Salaffi, W. Grassi
CER12128
2020,38,3
Pg. 0479-0487
Free to view
IL-34 modulates rheumatoid synovial fibroblasts proliferation and migration via ERK/AKT signalling pathway
A. Elkhider, J. Wei, M. Al-Azab, Y. Tang, W. Walana, W. Li, B. Yuan, Y. Ye, G. Wang, Y. Zhang, X. Li
A. Elkhider, J. Wei, M. Al-Azab, Y. Tang, W. Walana, W. Li, B. Yuan, Y. Ye, G. Wang, Y. Zhang, X. Li
CER12354
2020,38,3
Pg. 0488-0499
Free to view
The Comprehensive Rheumatologic Assessment of Frailty (CRAF): development and validation of a multidimensional frailty screening tool in patients with rheumatoid arthritis
F. Salaffi, M. Di Carlo, S. Farah, M. Carotti
F. Salaffi, M. Di Carlo, S. Farah, M. Carotti
CER12439
2020,38,3
Pg. 0500-0507
Free to view
Variation in the synovial fluid metabolome according to disease activity of rheumatoid arthritis
J.K. Ahn, J. Kim, Y.E. Cheong, K.H. Kim, H.-S. Cha
J.K. Ahn, J. Kim, Y.E. Cheong, K.H. Kim, H.-S. Cha
CER12429
2020,38,3
Pg. 0508-0515
Free to view
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
N. Simons, Y. Degboé, T. Barnetche, A. Cantagrel, A. Ruyssen-Witrand, A. Constantin
N. Simons, Y. Degboé, T. Barnetche, A. Cantagrel, A. Ruyssen-Witrand, A. Constantin
CER12416
2020,38,3
Pg. 0516-0522
Free to view
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study
G.L. Erre, A. Piras, M. Piga, A.L. Fedele, A.A. Mangoni, P.E. Lazzerini, E. Gremese, A. Mathieu, G. Ferraccioli, G. Passiu, P.S. Saba
on behalf of the EDRA study group.
G.L. Erre, A. Piras, M. Piga, A.L. Fedele, A.A. Mangoni, P.E. Lazzerini, E. Gremese, A. Mathieu, G. Ferraccioli, G. Passiu, P.S. Saba
on behalf of the EDRA study group.
CER12427
2020,38,3
Pg. 0523-0528
Free to view
Validation of two frailty questionnaires in older patients with rheumatoid arthritis: a cross-sectional study
S. Oetsma, A. Boonen, M. Starmans, R. Peeters, M. Van Onna
S. Oetsma, A. Boonen, M. Starmans, R. Peeters, M. Van Onna
Brief Papers
CER13497
2020,38,3
Pg. 0529-0532
Free to view
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19
S. Sciascia, F. Aprà, A. Baffa, S. Baldovino, D. Boaro, R. Boero, S. Bonora, A. Calcagno, I. Cecchi, G. Cinnirella, M. Converso, M. Cozzi, P. Crosasso, F. De Iaco, G. Di Perri, M. Eandi, R. Fenoglio, M. Giusti, D. Imperiale, G. Imperiale, S. Livigni, E. Manno, C. Massara, V. Milone, G. Natale, M. Navarra, V. Oddone, S. Osella, P. Piccioni, M. Radin, D. Roccatello, D. Rossi
S. Sciascia, F. Aprà, A. Baffa, S. Baldovino, D. Boaro, R. Boero, S. Bonora, A. Calcagno, I. Cecchi, G. Cinnirella, M. Converso, M. Cozzi, P. Crosasso, F. De Iaco, G. Di Perri, M. Eandi, R. Fenoglio, M. Giusti, D. Imperiale, G. Imperiale, S. Livigni, E. Manno, C. Massara, V. Milone, G. Natale, M. Navarra, V. Oddone, S. Osella, P. Piccioni, M. Radin, D. Roccatello, D. Rossi
CER12488
2020,38,3
Pg. 0533-0535
Free to view
Cardiovascular risk in patients with new gout: should we reclassify the risk?
M. Gamala, J.W. Jacobs, S.P. Linn-Rasker, M. Nix, B.G. Heggelman, P.C. Pasker-De jong, J.M. Van Laar, R. Klaasen
M. Gamala, J.W. Jacobs, S.P. Linn-Rasker, M. Nix, B.G. Heggelman, P.C. Pasker-De jong, J.M. Van Laar, R. Klaasen
Reviews
CER12322
2020,38,3
Pg. 0536-0542
Free to view
Imaging in the preclinical phases of rheumatoid arthritis
A. Zabotti, S. Finzel, X. Baraliakos, K. Aouad, N. Ziade, A. Iagnocco
A. Zabotti, S. Finzel, X. Baraliakos, K. Aouad, N. Ziade, A. Iagnocco
CER12287
2020,38,3
Pg. 0543-0551
Free to view
LTB4-induced anti-apoptosis and infiltration of neutrophils in rheumatoid arthritis
K.-X. Li, L.-X. Zheng, H.-Q. Guo, F.-F. Hong, S.-L. Yang
K.-X. Li, L.-X. Zheng, H.-Q. Guo, F.-F. Hong, S.-L. Yang
Paediatric Rheumatology
CER12454
2020,38,3
Pg. 0552-0557
Free to view
Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood
S. Demir, O. Soyer, Y. Bilginer, E. Sag, U.M. Sahiner, B. Buyuktiryaki, B.E. Sekerel, S. Ozen
S. Demir, O. Soyer, Y. Bilginer, E. Sag, U.M. Sahiner, B. Buyuktiryaki, B.E. Sekerel, S. Ozen
CER12705
2020,38,3
Pg. 0558-0566
Free to view
Dural sinus thrombosis and giant pulmonary artery aneurysm in paediatric Behçet’s disease
L.L. Zhuang, H.M. Liu, G.M. Li, J. Shen, F. Liu, M. Ye, W.Z. Guan, Y.F. Li, T. Zhang, L. Sun
L.L. Zhuang, H.M. Liu, G.M. Li, J. Shen, F. Liu, M. Ye, W.Z. Guan, Y.F. Li, T. Zhang, L. Sun
Letters to the Editor
CER12747
2020,38,3
Pg. 0567-0568
Free to view
Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis
X.-Y. Cao, J.-L. Zhao, Y. Hou, F.-D. Wang, Z.-H. Lu
X.-Y. Cao, J.-L. Zhao, Y. Hou, F.-D. Wang, Z.-H. Lu
CER12336
2020,38,3
Pg. 0569-0570
Free to view
Hypogammaglobulinaemia in identical twin sisters with rheumatoid arthritis
M. Krasselt, C. Baerwald, O. Seifert
M. Krasselt, C. Baerwald, O. Seifert
CER12661
2020,38,3
Pg. 0571-0572
Free to view
Work participation and sick leave in women with systemic lupus erythematosus and matched controls during and after pregnancy
B.S. Blomjous, M.M. Ter Wee, C.N. Abheiden, A.E. Voskuyl, J.I. De Vries, I.E. Bultink
B.S. Blomjous, M.M. Ter Wee, C.N. Abheiden, A.E. Voskuyl, J.I. De Vries, I.E. Bultink
CER12859
2020,38,3
Pg. 0573-0574
Free to view
Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
I. Pirker, A. Rubbert-Roth, J. Von Kempis, M. Fehr, T. Neumann
I. Pirker, A. Rubbert-Roth, J. Von Kempis, M. Fehr, T. Neumann
CER12900
2020,38,3
Pg. 0575-0576
Free to view
Distribution of the components of the MDA response among patients with psoriatic arthritis with and without an acceptable symptomatic state
R. Queiro, E. Pardo, L. Charca
R. Queiro, E. Pardo, L. Charca
CER13479
2020,38,3
Pg. 0577
Free to view
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?
E. Elefante, C. Tani, D. Zucchi, V. Signorini, F. Ferro, M. Mosca
E. Elefante, C. Tani, D. Zucchi, V. Signorini, F. Ferro, M. Mosca
CER13578
2020,38,3
Pg. 0578
Free to view
Early tocilizumab treatment could improve survival among COVID-19 patients
L. Campins, R. Boixeda, L. Perez-Cordon, R. Aranega, C. Lopera, L. Force
L. Campins, R. Boixeda, L. Perez-Cordon, R. Aranega, C. Lopera, L. Force
CER13482
2020,38,3
Pg. 0579
Free to view
Anakinra in COVID-19 therapy: what have we learned from adult-onset Still’s disease?
S. Bilia, D. Giannini, G.M.L. Rizzelli, A. Tavoni
S. Bilia, D. Giannini, G.M.L. Rizzelli, A. Tavoni
CER13519
2020,38,3
Pg. 0580
Free to view
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart
C. Perricone, P. Conigliaro, C. Ciccacci, E. Marcucci, G. Cafaro, E. Bartoloni, R. Perricone, G. Novelli, P. Borgiani, R. Gerli
C. Perricone, P. Conigliaro, C. Ciccacci, E. Marcucci, G. Cafaro, E. Bartoloni, R. Perricone, G. Novelli, P. Borgiani, R. Gerli
CER12793
2020,38,3
Pg. 0581-0582
Free to view
Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting
V. Manfreda, M.S. Chimenti, C. Canofari, M. Esposito, R. Perricone, L. Bianchi, A. Giunta
V. Manfreda, M.S. Chimenti, C. Canofari, M. Esposito, R. Perricone, L. Bianchi, A. Giunta
CER12842
2020,38,3
Pg. 0583-0584
Free to view
Corticosteroid therapy for rheumatoid arthritis masking double ectopic parathyroid adenomas
G. Boutzios, H.M. Moutsopoulos
G. Boutzios, H.M. Moutsopoulos
Erratum Corrige
CER13617
2020,38,3
Pg. 0585
Free to view
Erratum corrige: “Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study”. J.L. Pablos et al.
J.L. Pablos, F. Navarro, F.J. Blanco, J.A. Román-Ivorra, A. Alonso, E. Martín Mola, M. Cantalejo, L. Ercole, N. Rivero
J.L. Pablos, F. Navarro, F.J. Blanco, J.A. Román-Ivorra, A. Alonso, E. Martín Mola, M. Cantalejo, L. Ercole, N. Rivero